Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Novavax, a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, announced its participation in the 42th Annual J.P. Morgan Healthcare Conference. The conference will include a presentation and Q&A session on January 8, 2024, with John C. Jacobs, President and Chief Executive Officer, as a participant. A replay of the recorded presentation and Q&A will be available on the company's website for 30 days.

GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the 42^th Annual J.P. Morgan Healthcare Conference.

Conference Details:
Presentation and Q&A
Date:		Monday, January 8, 2024
Time:		5:15 – 5:55 p.m. Pacific Standard Time (PST)
Location:		Westin St. Francis Hotel in San Francisco, California
Moderator:		Eric Joseph, Ph.D., Executive Director, Biotechnology Equity Research
Novavax participants:		John C. Jacobs, President and Chief Executive Officer
Conference
Event:		Investor Meetings
Date:		Monday, January 8, 2024

Recordings
A replay of the recorded presentation and Q&A will be available through the Events & presentations page of the Company's website at ir.novavax.com for 30 days from the date of the conference.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza and COVID-19 and influenza combined. Please visit novavax.com and LinkedIn for more information.

Contacts:
Investors
Erika Schultz
240-268-2022
ir@novavax.com 

Media
Ali Chartan
240-720-7804
media@novavax.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-42nd-annual-jp-morgan-healthcare-conference-302024821.html

SOURCE NOVAVAX, INC

FAQ

What is Novavax, Inc.'s ticker symbol?

The ticker symbol for Novavax, Inc. is NVAX.

When is Novavax, Inc. participating in the 42nd Annual J.P. Morgan Healthcare Conference?

Novavax, Inc. is participating in the conference on Monday, January 8, 2024.

Who will be the participant from Novavax, Inc. at the conference?

John C. Jacobs, President and Chief Executive Officer, will be representing Novavax, Inc. at the conference.

Where can the recorded presentation and Q&A be accessed?

The recorded presentation and Q&A will be available through the Events & presentations page of the Company's website at ir.novavax.com for 30 days from the date of the conference.